INTRODUCTION y-Carboxyglutamic acid (Gla)l has recently been found in the four vitamin K-dependent blood-clotting proteins (1-3), in proteins from bone (4, 5) , and in another plasma protein, protein C, the function of which is presently unknown (6) . In proteins, this amino acid is produced by a posttranslational carboxylation of specific glutamic acid residues in the precursor protein by a vitamin K-dependent and bicarbonate ion-requiring reaction which has been studied in liver (7) and kidney (8) microsomes. The formation of Gla in the chicken bone protein is also vitamin Kdependent (9) and bicarbonate ion-requiring (10) . In prothrombin, these Gla residues act as calciumbinding sites essential for the vital calcium-and phospholipid-dependent conversion of prothrombin to thrombin. If this carboxylation reaction is inhibited in vivo by coumarin-type anticoagulants or by vitamin K deficiency, the prothrombin protein, which is deficient in y-carboxyglutamic acid, exhibits only weak, relatively nonspecific interaction with calcium ions, and the conversion to thrombin in the normal clotting cascade sequence is greatly retarded (11) .
Since the Gla residues in the blood-clotting proteins appear to have calcium-binding properties essential for their normal physiological function, it appears possible that other proteins which are involved in other functions involving calcium ions may also contain this specific amino acid. Using a simple and reliable method developed in our laboratory for the quantitative measurement of Gla in proteins (4), we report the presence of Gla both in proteins of the organic matrix of only those renal calculi containing calcium and in certain urinary proteins.
METHODS
Renal calculi. Five types of urinary calculi, of which the major crystalline constituent (greater than 95%) was characterized by polarization microscopy and X-ray diffraction as calcium oxalate, hydroxyapatite, magnesium ammonium phosphate (struvite), mixtures of hydroxyapatite and struvite, uric acid, and cystine, were utilized in these studies. Except for the struvite stones which were obtained constantly-boiling 6 N HC1 in vacuo for 24 h at 105°C. (c) Phosphoserine content: for the routine detection of 0-phosphoserine, 3 mg of protein was hydrolyzed in 4 N HC1 for 6 h in vacuo at 105°C (12) . A timed series ofhydrolyses (from 1 to 24 h) was also carried out to determine the destruction of O-phophoserine under the conditions used. When these data were extrapolated to zero time, it was found that, in 4 N HCI at 105°C for 6 h, approximately 70% of the 0-phosphoserine was recovered. Similar studies of 0-phosphothreonine revealed that only 30% of the 0-phosphothreonine content was recovered after similarly timed hydrolysis.
Amino acid analysis. A Beckman/Spinco model 121 amino acid analyzer (Beckman Instruments, Inc. Spinco Div., Palo Alto, Calif.) equipped with a single column (0.28 x 33.0 cm) of Beckman AA-20 resin and an integrator system was used. (a) Gla program: for the complete separation of Gla from taurine and cysteic acid, a short program was run employing a stepped series 0.2 M citrate buffer from pH 2.70 to 3.44. The position of Gla was determined with an authentic sample obtained from Dr. Richard Hiskey of the University of North Carolina at Chapel Hill. The amount of Gla was quantitated using the color factor for Gla obtained with the authentic compound. The content of glutamic acid was obtained by subtracting the number of Gla residues from the total number ofglutamic acid residues found after hydrolysis in 6 N HCI for 24 h at 108°C. (b) Total amino acid analysis was performed using the standard Beckman program. (c) Phosphoserine program: 0-phosphoserine and 0-phosphothreonine were separated from cysteic acid, and taurine employing 0.2 M sodium citrate buffer, pH 1.6.
Isolation of Gla and decarboxylation to glutamic acid. Alkaline hydrolysates of 25 mg of the EDTA-soluble proteins from calcium oxalate stones with putative Gla were applied to a preparative amino acid column (90 x 6 cm) containing Technicon Chromobeads type A resin (Technician Instruments Corp., Tarrytown, N. Y.) and equipped with a split stream collecting 97% in 2.5-ml fractions and monitoring 3% by ninhydrin. The Gla was eluted with pH 2.5, 0.2 M citrate buffer and found to be in one tube. Part of the fraction was adjusted to pH 1.0 with 1 N HCI on ice and divided into equal aliquots which were placed in sealed ampoules and heated in a boiling water bath for 5, 10, 15, 20, and 40 min. The decarboxylation reaction was stopped at the specified times by placing the sealed ampoule on ice. Each aliquot and a portion of the original fraction were analyzed for its Gla and glutamic acid contents.
Fractionation of the EDTA extract of calcium oxalate and calcium hydroxyapatite stones. 150 mg of EDTA-extracted material from either calcium oxalate or hydroxyapatite stones were dissolved in 5 ml of 0.05 M NH4HCO3 buffer and applied to a Sephadex G-100 column (Pharmacia Fine Chemicals, Inc., Div. of Pharmacia, Inc., Piscataway, N. J.) 2.5 x 90 cm equilibrated in 0.05 M NH4HCO3 at room temperature. The sample was eluted with the same buffer at 15 mlVh in 3-ml fractions. Each fraction was read in a Zeiss spectrophotometer (Carl Zeiss, Inc., New York) at 230 nm. Sodium dodecyl sulfate (SDS) gel electrophoresis was performed by the method of Shapiro et al. (13) . Molecular weights were determined in 10 and 12% acrylamide gels which were stained in Coomassie Blue.
Analysis of urine samples. 24-h urines were collected from three adults with no family history of renal calculi and from three patients who are recurrent stone formers. Urines were dialyzed exhaustively against water in Spectrophor I and lyophilized. The material was analyzed for Gla by 2 N KOH hydrolysis for protein content by standard amino acid analysis. dues/1,000 total amino acid residues. The extracts obtained from apatite-struvite stones contained from 12 to 22 residues of Gla/l,000 total amino acid residues, whereas the EDTA extract of the hydroxyapatite stones contained 25 residues of Gla/1,000 amino acid residues. The uric acid stones and the cystine stone pools contained either no Gla or only trace amounts of Gla. Pure magnesium ammonium phosphate stones of canine origin were also found to contain only trace amounts of Gla (< 1 residue/1,000 amino acids). Fig. 1A demonstrates the ninhydrin-positive peak at the position of Gla obtained from the alkaline hydrolysate of the EDTA-soluble, nondialyzable proteins from the calcium oxalate stones. The putative Gla peak disappears if the alkaline hydrolysate is boiled at pH< 1 for 1 h before amino acid analysis. The identity of this peak as Gla was confirmed by isolation of a sufficient quantity of the amino acid which converted to glutamic acid when subjected to heat-and acid-catalyzed decarboxylation. The putative Gla fraction, isolated on the preparative column from a 25-mg hydrolysate, is observed to be free from the other acidic components when chromatographed in a Beckman 121-M analyzer (Fig. 1B) . When this fraction was heated to 100°C at pH 1.0, it was converted only to glutamic acid (Fig. iC) .
The half-time conversion of Gla to glutamic acid under these conditions was the same (9 min) as found with authentic Gla.
Gel filtration of the EDTA extract from calcium oxalate stones on Sephadex G-100 yielded five fractions (Fig. 2) . Different pools had similar but not identical profiles with differences observed in the relative yields of peaks 2 and 5. The Gla-rich fraction, peak 4, usually accounted for 25% of the protein content in the EDTA extract.
The percent protein in each fraction, its Gla, phosphoserine, and partial amino acid composition are summarized in Table II . A significant amount of 0-phosphoserine and 0-phosphothreonine were found in the lower molecular weight or retarded G-100 fractions. The marked destruction of O-phosphothreonine combined with the relatively small amount present, precluded an accurate calculation of its content. Qualitatively, it appeared to be present at a concentration less than 10% of the 0-phosphoserine. The apparent molecular weight ofthe major component in each fraction is also given in Table II , and the SDS dics gels of each fraction are shown in Fig. 3 . Peak 5 traveled with the buffer front and stained very poorly. The Gla-rich, peak 4 fraction (with 44 residues/1,000) has an apparent molecular weight of 17,000 daltons.
The soluble, nondialyzable proteins in the EDTA extract from hydroxyapatite stones was similarly fractionated by gel filtration on a Sephadex G-100 column. A fraction eluting in the same area as peak 4 (14) .
These investigators also noted that there were significant differences in the amino acid compositio'n of certain of the partially purified proteins derived from the calcium oxalate, apatite struvite, and uric acid stones, perhaps related to the differences in the structure of the crystalline component of the stones. In the present study, another very distinct difference between the proteins derived from the various renal calculi was detected, namely, that only the proteins associated with calcium-containing calculi contained Gla. The protein in the calcium oxalate and the hydroxyapatite stones had a consistently high level of Gla, whereas the proteins associated with uric acid, cystine, and struvite did not contain Gla. The calculi composed of both struvite and hydroxyapatite contained a variable amount of Gla roughly in proportion to the percentage of hydroxyapatite present. Thus it appears that the Gla content correlates with the calcium content of the stones and not with the total y-Carboxyglutamic Acid in Calcium-Containing Renal Calculicontent of matrix protein or with the presence of Gla in the urine. The analysis of the pure struvite (MgNH4PO4) stones, such as are found in dogs (and not in humans), shows an absence of Gla which is consistent with the above speculation. Although this is a cross-species comparison, we have shown that dog urine contains Gla (vide infra). The presence of Gla in calcium-containing stones is consistent with the known calcium-binding properties of protein-bound Gla (1, 2) . The additional presence ofO-phosphoserine in the proteins ofthese renal stones may not only be important in the binding of the calcium ions but also in fixing their stereochemical configuration, especially if the carboxyl groups are in close juxtaposition to the O-phosphoserine residues as they are in the enamel proteins (15) .
To date, Gla has been identified as a component of the vitamin K-dependent blood-clotting factors (3), in a plasma protein, protein C (6) , and in the EDTAsoluble, nondialyzable proteins of chicken and bovine bone (4, 5) . The major protein components of the calcium-containing stones is relatively rich in this unique calcium-binding amino acid, to the same degree as the F1 fragment from prothrombin (64 residues/1,000) (3) and the protein from bone (60 residues/1,000). A comparison of the amino acid composition of the purified Gla-containing protein ofrenal calculi with the other known Gla-containing proteins, however, shows marked differences in the amino acid composition, particularly in the aspartic acid and arginine content. This makes it highly unlikely that the Gla-containing protein(s) of renal calculi represent any of the known Gla-containing proteins such as prothrombin or the bone protein. Thus it seems most likely that the Gla-containing proteins extracted from renal calculi represent still another distinct class of proteins containing Gla.
Although the preliminary results have demonstrated the presence of Gla-containing protein(s) in the urine of normal and stone-forming patients, the relationships among the proteins excreted in the urine, the known serum and bone proteins, and the proteins obtained from renal calculi are unclear. In this regard, the recent finding that kidney microsomes synthesize a protein containing Gla is of great significance (8).
It is not possible at this time to ascribe a function to the Gla-containing proteins of renal calculi. Glacontaining proteins have been detected in the ectopic calcifications of soft tissues which do not normally contain Gla (16) . In both this instance and in the case of the Gla-containing proteins associated with the bone matrix, it is not clear whether the protein is associated with the initiation of calcification, whether it represents an inhibitor of mineralization, or whether it arises by virtue of the fact that the Gla-containing proteins are adsorbed to the calcium-containing calculi much as they may be fractionated on columns of hydroxyapatite due to the binding of the Gla residues to calcium (4) . On the other hand, although the exact biochemical mechanisms involved in the formation of renal calculi are not known either in general or for any of the specific types of renal stone, it is clear from both theoretical and experimental considerations that a solution to solid-phase transformation is unlikely to occur only by simple homogeneous nucleation (17) . It has not yet been established whether the first fragments of the solid mineral phase are initially formed on the surfaces of various microscopic or ultrastructural components in the kidney, as suggested by Caulfield and Schrag (18) , or are nucleated in solution by interactions of the renal calculi components (Ca++, P04=, uric acid, oxalate) with specific macromolecular components in solution (19) , but in any event, the process is undoubtedly initiated by heterogeneous nucleation. Thus it is tempting to speculate that the Gla-containing protein may serve as the nucleation substrate, although an equally plausible argument can be advanced that they function in just the opposite way. Similar considerations (16) have evolved concerning the possible role of the phosphoproteins in the initiation of calcification in enamel (15) , bone (20) , and dentin (21) .
Further investigations on the nature of the Glacontaining protein of renal calculi, their site of synthesis, their Ca++-interaction properties, and the number, configuration, and interaction properties of the bound calcium ions (17) , as well as their relationship to the proteins in the urine containing Gla, may shed light on their physiological role.
